Richie Porte 'flabbergasted' and 'in shock' over Chris Froome anti-doping investigation
Porte describes his reaction to hearing news of UCI investigation into friend and former team-mate
Richie Porte has described how he was "flabbergasted" and "in massive shock" when he received the news that friend and former team-mate Chris Froome was under investigation by the UCI after delivering an adverse analytical finding for salbutamol.
Speaking after finishing third in the time trial at the Australian Road National Championships, Porte said that there was little he could say on the matter.
"There's not really much you can say. Whatever you say, you can't win," Porte told the AAP.
>>> Greg LeMond: 'Chris Froome broke the rules so he should be punished'
"It's a big shame. When I heard the news, it was a massive shock. Let's see what happens, let it all run its course. I'm flabbergasted, as you guys are.
"I do have respect [for Froome]. He is a good friend and we were team-mates for a long time. It is only natural you are going to ask the questions but I'd probably rather not say too much."
Watch: Top 10 riders of 2017
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Porte was not the only rider to be asked about Froome' salbutamol case after Friday's time trial, with race winner Rohan Dennis saying that if he was in the same situation as Froome then he would take full responsibility for the test results.
"I've made it no secret that I have a zero tolerance for any sort of positive test and that goes for myself," Dennis said.
"If I accidentally or purposefully take something – which I never would, purposefully take something – then I'd just have to own it and get a slap on the wrist.
"I don't know the full details, but for myself, if that was me, I'd just say 'Look, I screwed up, I shouldn't have done this, or what-not'."
>>> Everything you need to know about Chris Froome's salbutamol case
Froome is currently under investigation by the UCI after being found to have a high concentration of the asthma drug salbutamol in his urine after stage 17 of the 2017 Vuelta a España.
Froome denies exceeding the permitted dosage for the drug, and must now prove that the high concentration of the drug in his system was not as a result of exceeding the maximum permitted dosage of 800 micrograms per 12 hours.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.
-
‘There's no point to race for 50th place’: Peter Sagan explains why he’s a cycling esports ambassador but won’t compete
As a MyWhoosh ambassador, Sagan admires the sport’s evolution, but does he have the watts to compete with today’s virtual cycling stars?
By Christopher Schwenker Published
-
Rapha's loss, your gain: prices slashed sitewide amid profitability concerns
The British clothing brand unveils an almost unheard-of 25% discount across its entire product range
By Hannah Bussey Published
-
Chris Froome misses out on Tour de France selection
39-year-old absent from Israel-Premier Tech's eight-rider roster
By Tom Davidson Published
-
A complete history of Ineos Grenadiers kits, from Adidas to Gobik, via Rapha
The British team switch to Gobik in 2024 after two years with Bioracer
By Tom Thewlis Published
-
Chris Froome's boss rubbishes claims bike fit is behind lack of results
'He can talk about his bike position until the cows come home - that's still not going to earn him a position on a Grand Tour team' says Israel-Premier Tech team owner Sylvan Adams
By Tom Thewlis Published
-
Chris Froome, rim brake evangelist, 'warms to' disc brakes
The Israel-Premier Tech rider, also an investor at Factor Bikes, says that he has "way less problems" with discs these days
By Adam Becket Published
-
Is Chris Froome - in 2023 - a professional cyclist, or an influencer?
The seven-time Grand Tour winner hasn't raced since July, but has taken to being interesting on social media
By Adam Becket Published
-
Chris Froome 'absolutely not' worth multi-million euro salary says his team boss
The four-time Tour de France winner was not selected for this year's Tour de France for performance reasons, Israel-Premier Tech boss Sylvan Adams says
By Chris Marshall-Bell Published
-
Chris Froome not selected for Tour de France 2023
38-year-old misses out on 'ultimate goal' as Israel-Premier Tech confirm eight-man squad
By Tom Davidson Published
-
Back to Africa: Chris Froome on going back to his roots, his future and cycling's new generation
He’s come full circle, but is there time for another loop? We talk to the four-time Tour champ about his and African cycling’s future
By Adam Becket Published